Furqan Ahmed

Furqan Ahmed possesses extensive experience in business development and strategic roles within the pharmaceutical and biotechnology sectors, currently serving as a Mentor (Volunteer) at Nucleate since February 2025. Prior to this, Furqan held the position of VP & Head of Business Development at Biosion from July 2023 to May 2025 and was VP of Business Development at Immunome, Inc. from November 2021 to June 2023. Between December 2018 and November 2021, Furqan worked as Director of Corporate Strategy and Business Development at Eisai US, along with prior roles at Antares Pharma Inc. and Merck, which included leadership positions in business development and corporate strategy. Furqan began the professional journey as a Regulatory Affairs Intern at Schering Plough, following an Equity Research Internship at Needham & Company. Educationally, Furqan obtained a Doctor of Pharmacy (PharmD) degree from Rutgers Pharmacy, completing the program in 2008.